Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Active, not recruiting · NCT05806814 · Registry updated 2026-05-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Active, not recruiting | Phase 1 | 2026-05-27 | NCT05806814 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dendreon | 5 |
| University of Oklahoma | 146 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Oklahoma Health Sciences Center, Stephenson Cancer Center | Oklahoma City | United States | 1 |